• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有骨化生及惰性生物学行为的重排性肾细胞癌

-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour.

作者信息

Aldera Alessandro Pietro, Ramburan Amsha, John Jeff

机构信息

Division of Anatomical Pathology, Faculty of Health Sciences, University of Cape Town, South Africa.

JDW Pathology Inc, Cape Town, South Africa.

出版信息

Urol Case Rep. 2022 Feb 25;42:102041. doi: 10.1016/j.eucr.2022.102041. eCollection 2022 May.

DOI:10.1016/j.eucr.2022.102041
PMID:35530544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9073298/
Abstract

TFE3-rearranged renal cell carcinoma (RCC) is a rare but well characterised histological subtype of RCC with an aggressive clinical course and propensity for late metastases. Osseous metaplasia is an uncommon but well documented finding in clear cell, papillary and chromophobe RCC. We present the first case of a -rearranged RCC to be found harbouring metaplastic bone in a 47-year-old woman who presented with a slowly enlarging left flank mass over a 10 year period. This case report adds to the clinicopathological description of -rearranged RCC and suggests that larger studies are required to fully elucidate the prognosis of these tumours.

摘要

TFE3 重排肾细胞癌(RCC)是一种罕见但特征明确的肾细胞癌组织学亚型,临床病程侵袭性强,易发生晚期转移。骨化生在透明细胞型、乳头状和嫌色细胞型肾细胞癌中并不常见,但已有充分记录。我们报告首例TFE3重排肾细胞癌病例,该病例发生于一名47岁女性,她在10年期间出现左侧腰部缓慢增大的肿块,且伴有化生骨。本病例报告补充了TFE3重排肾细胞癌的临床病理描述,并表明需要进行更大规模的研究以充分阐明这些肿瘤的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/f839da2e5958/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/f202ffb1991a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/3fd31e2779e7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/f839da2e5958/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/f202ffb1991a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/3fd31e2779e7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4432/9073298/f839da2e5958/gr3.jpg

相似文献

1
-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour.伴有骨化生及惰性生物学行为的重排性肾细胞癌
Urol Case Rep. 2022 Feb 25;42:102041. doi: 10.1016/j.eucr.2022.102041. eCollection 2022 May.
2
TFE3-rearranged RCC with osseous metaplasia found on bone mass densitometry.骨密度测定发现伴有骨化生的TFE3重排性肾细胞癌。
Ann Med Surg (Lond). 2024 Aug 14;86(10):6198-6202. doi: 10.1097/MS9.0000000000002479. eCollection 2024 Oct.
3
Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.与Xp11.2易位/TFE3基因融合相关的成人肾癌组织学谱系中的诊断陷阱。
Med Mol Morphol. 2010 Jun;43(2):86-90. doi: 10.1007/s00795-008-0423-x. Epub 2010 Aug 4.
4
TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma.TFE3基因重排和蛋白表达导致肾细胞癌预后不良。
Heliyon. 2023 May 6;9(5):e16076. doi: 10.1016/j.heliyon.2023.e16076. eCollection 2023 May.
5
Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis.TFE3 重排性肾细胞癌病例报告:氟代脱氧葡萄糖正电子发射断层显像摄取情况可能有助于诊断。
J Kidney Cancer VHL. 2023 Sep 27;10(3):61-68. doi: 10.15586/jkcvhl.v10i3.266. eCollection 2023.
6
Papillary Renal Cell Carcinoma in Transplanted Kidney and Xp11.2 Translocation/Transcription Factor E3-Rearranged Renal Cell Carcinoma in the Native Kidney: A Case Report.移植肾中的乳头状肾细胞癌与原发性肾中的Xp11.2易位/转录因子E3重排肾细胞癌:1例报告
J Korean Soc Radiol. 2024 Mar;85(2):437-444. doi: 10.3348/jksr.2023.0102. Epub 2024 Mar 26.
7
Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.Xp11.2 易位/TFE3 基因融合相关性成人肾细胞癌的超声造影表现:与透明细胞肾细胞癌和乳头状肾细胞癌的比较。
Cancer Imaging. 2019 Dec 31;20(1):1. doi: 10.1186/s40644-019-0268-7.
8
Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities.重排性肾细胞癌的临床病理特征及TFE3、TFEB和ALK在肾脏实体中的染色表现探索。
Heliyon. 2023 Apr 3;9(4):e15159. doi: 10.1016/j.heliyon.2023.e15159. eCollection 2023 Apr.
9
RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.RBM10-TFE3 肾细胞癌的特征为中心体旁倒位,断裂分离荧光原位杂交显示一致的紧密分裂信号:10 例研究及文献复习。
Histopathology. 2019 Aug;75(2):254-265. doi: 10.1111/his.13866. Epub 2019 Jun 25.
10
TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients.TFE3 重排型成人肾细胞癌:一项大型连续治疗患者队列的临床病理特征和结局分析。
Am J Surg Pathol. 2012 May;36(5):663-70. doi: 10.1097/PAS.0b013e31824dd972.

引用本文的文献

1
TFE3-Rearranged Renal Cell Carcinoma With Osseous Metaplasia: A Case Report of a Rare Entity With an Unusual Finding.伴骨化生的TFE3重排肾细胞癌:1例具有罕见异常表现的罕见病例报告
Cureus. 2024 Nov 5;16(11):e73072. doi: 10.7759/cureus.73072. eCollection 2024 Nov.
2
TFE3-rearranged RCC with osseous metaplasia found on bone mass densitometry.骨密度测定发现伴有骨化生的TFE3重排性肾细胞癌。
Ann Med Surg (Lond). 2024 Aug 14;86(10):6198-6202. doi: 10.1097/MS9.0000000000002479. eCollection 2024 Oct.
3
Clinical Characteristics of Molecularly Defined Renal Cell Carcinomas.

本文引用的文献

1
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.在肾脏肿瘤咨询服务中使用 TFE3 断裂 FISH 检测。
Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.
2
TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients.TFE3 重排型成人肾细胞癌:一项大型连续治疗患者队列的临床病理特征和结局分析。
Am J Surg Pathol. 2012 May;36(5):663-70. doi: 10.1097/PAS.0b013e31824dd972.
3
Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
分子定义的肾细胞癌的临床特征
Curr Issues Mol Biol. 2023 May 31;45(6):4763-4777. doi: 10.3390/cimb45060303.
与Xp11.2易位/TFE3基因融合相关的成人肾癌组织学谱系中的诊断陷阱。
Med Mol Morphol. 2010 Jun;43(2):86-90. doi: 10.1007/s00795-008-0423-x. Epub 2010 Aug 4.